Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.23.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Revenue    
Product revenue, net $ 70,995 $ 63,134
Collaboration revenue 1,882 5,389
Revenue - related party 192 268
Other revenue 2,674 0
Net revenue 75,743 68,791
Operating expenses    
Cost of goods sold - product revenue 30,775 32,084
Research and development 134,199 113,240
Research and development - licenses acquired 677 15,625
Selling, general and administrative 113,656 86,843
Wire transfer fraud loss 0 9,540
Total operating expenses 279,307 257,332
Loss from operations (203,564) (188,541)
Other income (expense)    
Interest income 1,398 649
Interest expense and financing fee (13,642) (15,308)
Foreign exchange loss (89)  
Change in fair value of investments 0 39,294
Loss on common stock warrant liabilities 1,129 (447)
Grant income 1,304  
Total other income (expense) (9,900) 24,188
Loss before income tax expense (213,464) (164,353)
Income tax expense 449 473
Net loss (213,913) (164,826)
Net loss attributable to non-controlling interests 127,338 100,123
Net loss attributable to common stockholders $ (86,575) $ (64,703)
Net loss per common share attributable to common stockholders - basic $ (0.97) $ (0.79)
Net loss per common share attributable to common stockholders - diluted $ (0.97) $ (0.79)
Weighted average common shares outstanding - basic 88,874,519 81,700,220
Weighted average common shares outstanding - diluted 88,874,519 81,700,220